These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17899191)

  • 21. Intermittent Esotropia in 4 Patients With Allan-Herndon-Dudley Syndrome.
    Swiston CJ; Nash DL
    J Child Neurol; 2018 Jul; 33(8):525-527. PubMed ID: 29714107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care.
    Ramos HE; Morandini M; Carré A; Tron E; Floch C; Mandelbrot L; Neri N; De Sarcus B; Simon A; Bonnefont JP; Amiel J; Desguerre I; Valayannopoulos V; Castanet M; Polak M
    Eur J Endocrinol; 2011 Feb; 164(2):309-14. PubMed ID: 21098685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome.
    Maity-Kumar G; Ständer L; DeAngelis M; Lee S; Molenaar A; Becker L; Garrett L; Amerie OV; Hoelter SM; Wurst W; Fuchs H; Feuchtinger A; Gailus-Durner V; Garcia-Caceres C; Othman AE; Brockmann C; Schöffling VI; Beiser K; Krude H; Mroz PA; Hofmann S; Tuckermann J; DiMarchi RD; Hrabe de Angelis M; Tschöp MH; Pfluger PT; Müller TD
    Mol Metab; 2022 Dec; 66():101616. PubMed ID: 36270613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency.
    Masnada S; Groenweg S; Saletti V; Chiapparini L; Castellotti B; Salsano E; Visser WE; Tonduti D
    Metab Brain Dis; 2019 Dec; 34(6):1565-1575. PubMed ID: 31332729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.
    Schwartz CE; Stevenson RE
    Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):307-21. PubMed ID: 17574010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotonic male infant and MCT8 deficiency - a diagnosis to think about.
    Rodrigues F; Grenha J; Ortez C; Nascimento A; Morte B; M-Belinchón M; Armstrong J; Colomer J
    BMC Pediatr; 2014 Oct; 14():252. PubMed ID: 25284458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
    Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
    Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics and phenomics of thyroid hormone transport by MCT8.
    Friesema EC; Visser WE; Visser TJ
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):107-13. PubMed ID: 20083155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish.
    de Vrieze E; van de Wiel SM; Zethof J; Flik G; Klaren PH; Arjona FJ
    Endocrinology; 2014 Jun; 155(6):2320-30. PubMed ID: 24693966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy.
    Wirth EK; Sheu SY; Chiu-Ugalde J; Sapin R; Klein MO; Mossbrugger I; Quintanilla-Martinez L; de Angelis MH; Krude H; Riebel T; Rothe K; Köhrle J; Schmid KW; Schweizer U; Grüters A
    Eur J Endocrinol; 2011 Oct; 165(4):555-61. PubMed ID: 21813593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient Activation of Pathogenic ΔPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones.
    Braun D; Schweizer U
    Endocrinology; 2015 Dec; 156(12):4720-30. PubMed ID: 26368820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
    EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable Clinical Characteristics and Molecular Spectrum of Patients with Syndromes of Reduced Sensitivity to Thyroid Hormone: Genetic Defects in the THRB and SLC16A2 Genes.
    Choi JH; Cho JH; Kim JH; Yoo EG; Kim GH; Yoo HW
    Horm Res Paediatr; 2018; 90(5):283-290. PubMed ID: 30497070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone transporters--functions and clinical implications.
    Bernal J; Guadaño-Ferraz A; Morte B
    Nat Rev Endocrinol; 2015 Jul; 11(7):406-17. PubMed ID: 25942657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of the Thyroid Hormone Transporter Monocarboxylate Transporter 8 in Neural Progenitors Impairs Cellular Processes Crucial for Early Corticogenesis.
    Vancamp P; Deprez MA; Remmerie M; Darras VM
    J Neurosci; 2017 Nov; 37(48):11616-11631. PubMed ID: 29109240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation.
    Zada D; Tovin A; Lerer-Goldshtein T; Vatine GD; Appelbaum L
    PLoS Genet; 2014 Sep; 10(9):e1004615. PubMed ID: 25255244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocarboxylate transporter 10 functions as a thyroid hormone transporter in chondrocytes.
    Abe S; Namba N; Abe M; Fujiwara M; Aikawa T; Kogo M; Ozono K
    Endocrinology; 2012 Aug; 153(8):4049-58. PubMed ID: 22719050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].
    Tang YL; Peng J; Xiong J; Pang N; Wu LW; Yang HY; Kessi M; Yin F
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):829-834. PubMed ID: 30392207
    [No Abstract]   [Full Text] [Related]  

  • 40. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8.
    Wémeau JL; Pigeyre M; Proust-Lemoine E; d'Herbomez M; Gottrand F; Jansen J; Visser TJ; Ladsous M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2084-8. PubMed ID: 18334584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.